Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...
Data readouts over the next six months could set expectations for how the highly lucrative market for weight loss therapies ...
Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is ...
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
Compounding pharmacies sued the FDA after its declaration, bringing an end to the sale of the "copycat" drugs they provide. Meanwhile, as demand soars for weight loss drugs, WeightWatchers eyes ...
However, as of September 2024, the FDA has marked all Zepbound doses as available. One alternative may be Wegovy, another FDA-approved drug for weight management. Read our recommendations on how ...
These drugs work similarly but differ in dosage and specific indications (uses). Research suggests that tirzepatide is more ...
Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...